Marco Londei has sold ANAB and made no open-market buys since Dec 2018
Chief Medical Officer at AnaptysBio, Inc.
SEC CIK 0001654500 · Filings on SEC.gov ↗
$0Bought
$4.1MSold
NoneLast buy
Every filing
3 filings since Dec 2018, newest first
Filings come from SEC EDGAR. Not investment advice.